| [1] |
Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, et al. Regional citrate anticoagulation for continuous renal replacement therapy in children [J]. Pediatr Nephrol, 2017, 32(4): 703-711.
|
| [2] |
Chadha V, Garg U, Warady BA, et al. Citrate clearance in children receiving continuous venovenous renal replacement therapy [J]. Pediatr Nephrol, 2002, 17(10): 819-824.
|
| [3] |
Kaddourah A, Basu RK, Bagshaw SM, et al. Epidemiology of acute kidney injury in critically ill children and young adults [J]. N Engl J Med, 2017, 376(1): 11-20.
|
| [4] |
Klingele M, Stadler T, Fliser D, et al. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction [J]. Crit Care, 2017, 21(1): 294.
|
| [5] |
张燕，王英杰，许涛. 枸橼酸抗凝与肝素抗凝在重症患者持续肾脏替代治疗中的应用[J]. 医学理论与实践，2019, 32(12): 1804-1806.
|
| [6] |
Broman M, Klarin B, Sandin K, et al. Simplified citrate anticoagulation for CRRT without calcium replacement [J]. ASAIO J, 2015, 61(4): 437-442.
|
| [7] |
Fabra C, Infante S, Miras I, et al. Hematologic disorders in children with continuous renal replacement therapies [J]. ASAIO J, 2018, 64(3): 375-381.
|
| [8] |
Rodriguez K, Srivaths PR, Tal L, et al. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure [J]. PLoS One, 2017, 12(8): e0182134.
|
| [9] |
Sik G, Demirbuga A, Annayev A, et al.Continuous renal replacement therapy with citric acid and systemic heparin anticoagulation for critically ill children [J]. Int J Artif Organs, 2020, 43(4): 234-241.
|
| [10] |
Rico M, P′Fernandez S, J′Rojas VA, et al. Regional citrate anticoagulation for continuous renal replacement therapy in children [J]. Pediatr Nephrol, 2016, 32(4): 703-711.
|
| [11] |
Deep A, Zoha M, Dutta Kukreja P. Prostacyclin as an anticoagulant for continuous renal replacement therapy in children [J]. Blood Purif, 2017, 43(4): 279-289.
|
| [12] |
周新龙，郭瑶，李聪. 儿童重症高危出血患儿血液净化应用局部枸橼酸抗凝的疗效和安全性分析[J]．医学理论与实践，2020, 33(3): 450-452.
|
| [13] |
Musielak A, Warzywoda A, Wojtalik M, et al. Outcomes of continuous renal replacement therapy with regional center [J]. Ther Apher Dial, 2016, 20(6): 639-644.
|
| [14] |
崔庆宏，孙峰，刘树元，等. 急诊连续性肾脏替代治疗中局部枸橼酸抗凝应用情况的调查研究[J]. 中华危重病急救医学，2020, 32(5): 595-600.
|
| [15] |
Nurmohamed SA, Jallah BP, Vervloet MG, et al. Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency：a prospective observational study [J]．BMC Nephrol, 2013, 14: 89.
|
| [16] |
任卫红，张红梅，姚玉玲，等. 局部枸橼酸纳抗凝和普通肝素抗凝在血液滤过过程中的应用对比[J]．中国医学创新，2019, 16(2): 140-143.
|
| [17] |
项龙，任宏，奚悦玲，等. 局部枸橼酸抗凝技术在儿童连续肾脏替代治疗中的临床应用[J]．东南国防医药，2018, 20(5): 459-463.
|
| [18] |
郭妍南，明华，陈秀英，等. 枸橼酸钠抗凝在脓毒症伴急性肾损伤患儿连续性静脉-静脉血液滤过治疗中的应用[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(6): 726-730.
|
| [19] |
Soltysiak F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial [J]. Crit Care, 2015, 19(1): 91.
|
| [20] |
Uturovie-Ponikvar J. Is regional citrate anticoagulation the future of hemodialysis？[J]. Ther Apher Dial, 2016, 20(3): 234-239.
|
| [21] |
席春生，刘飞，刘同存，等. 高出血风险患者两段法枸橼酸抗凝血液透析的临床观察[J]. 临床肾脏病杂志，2018, 18(3): 141-144.
|
| [22] |
张珂，孔凌，龚德华，等. 改良枸橼酸输注法对连续性血液净化患者体外循环凝血的影响[J]. 解放军护理杂志，2018, 35(10): 25-28.
|
| [23] |
黄继红，徐卓明，龚霄雷，等. 含钙置换液简化先天性心脏病术后儿童血液滤过枸橼酸抗凝模式研究[J]. 中国小儿急救医学，2019, 26(3): 195-200.
|
| [24] |
Kirwan CJ, Hutchison R, Ghabina S, et al. Implementation of a simplified regional citrate anticoagulation protocol for post-dilution continuous hemofiltration using a bicarbonate buffered, calcium containing replacement solution [J]. Blood Purif, 2016, 42(4): 349-355.
|
| [25] |
王妍，张北源，郭晓芳，等. 重症患者局部枸橼酸抗凝行连续性静脉-静脉血液滤过离子钙浓度的探讨[J]. 肾脏病与透析肾移植杂志，2021, 30(2): 119-123.
|
| [26] |
Liet JM, Allain-Launay E, Gaillard-LeRoux B, et al. Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions [J]. Pediatr Nephrol, 2014, 29(9): 1625-1631.
|
| [27] |
席春生，刘飞，方春天，等. 自动局部枸橼酸抗凝连续肾脏替代治疗临床分析[J]. 中国中西医结合肾病杂志，2021, 22(2): 150-152.
|
| [28] |
Kakajiwala A, Jemielita T, Hughes JZ, et al. Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits [J]. Pediatr Nephrol, 2017, 32(7): 1251-1261.
|
| [29] |
Miklaszewska M, Korohoda P, Zachwieja K, et al. Filter size not the anticoagulation method is the decisive factor in continuous renal replacement therapy circuit survival [J]. Kidney Blood Press Res, 2017, 42(2): 327-337.
|
| [30] |
Persic V, Vajdic Trampuz B, Medved B, et al. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: focus on citrate accumulation [J]. Artif Organs, 2020, 44(5): 497-503.
|
| [31] |
Raymakers-Janssen PAMA, Lilien M, van Kessel IA, et al. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children [J]. Pediatr Nephrol, 2017, 32(10): 1971-1978.
|
| [32] |
Brophy PD, Somers MJ, Baum MA, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT) [J]. Nephrol Dial Transplant, 2005, 20(7): 1416-1421.
|
| [33] |
Yu Y, Peng S, Cen Z, et al. Applying regional citrate anticoagulation in continuous renal replacement therapy for acute kidney injury patients with acute liver dysfunction: a retrospective observational study [J]. Kidney Blood Press Res, 2018, 43(4): 1065-1074.
|
| [34] |
Akhoundi A, Singh B, Vela M, et al. Incidence of adverse events during continuous renal replacement therapy [J]. Blood Purif, 2015, 39(4): 333-339.
|
| [35] |
沈颖，易著文. 儿科血液净化技术[M]. 北京：清华大学出版社，2012: 47.
|